MRI for iron mapping in Alzheimer's disease

Neurodegenerative Diseases

Volumn 13, Issue 2-3, 2014, Pages 189-191

  Langkammer, Christian ^a   Ropele, Stefan ^a   Pirpamer, Lukas ^a   Fazekas, Franz ^a   Schmidt, Reinhold ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Amyloid plaques; Brain iron; Iron deposition; Neurodegeneration

Indexed keywords

IRON; FERRITIN;

AMYLOID PLAQUE; ARTICLE; BRAIN MAPPING; BRAIN TISSUE; EXPERIMENTAL MODEL; HIPPOCAMPUS; HUMAN; MOLECULAR DYNAMICS; MOUSE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULVINAR; PUTAMEN; RED NUCLEUS; SUSCEPTIBILITY WEIGHTED IMAGING; TEMPORAL CORTEX; THALAMUS; TRANSGENIC ANIMAL; ALZHEIMER DISEASE; AUTOPSY; CAUDATE NUCLEUS; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DEGENERATIVE DISEASE; DENTATE NUCLEUS; GRAY MATTER; LONGITUDINAL STUDY; MAGNETIC FIELD; PARIETAL CORTEX; QUANTITATIVE ANALYSIS; RELAXATION TIME; SENILE PLAQUE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN CHEMISTRY; BRAIN MAPPING; HUMANS; IRON; MAGNETIC RESONANCE IMAGING;

EID: 84896690191     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000353756     Document Type: Article

References (12)

1. Smith MA, Harris PL, Sayre LM, Perry G: Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997; 94: 9866-9868.
2. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA: MRI of brain iron. AJR Am J Roentgenol 1986; 147: 103-110.
3. Langkammer C, Krebs N, Goessler W, Scheurer E, Ebner F, Yen K, et al: Quantitative MRI of brain iron: a postmortem validation study. Radiology 2010; 257: 455-462.
4. Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E, et al: Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012; 62: 1593-1599.
5. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA: Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999; 96: 14079-14084.
6. Braakman N, Matysik J, Van Duinen SG, Verbeek F, Schliebs R, De Groot HJM, et al: Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006; 24: 530-536.
7. Parsey RV, Krishnan KR: Quantitative analysis of T2 signal intensities in Alzheimer's disease. Psychiatry Res 1998; 82: 181-185.
8. Schenck JF, Zimmerman EA: High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004; 17: 433-445.
9. House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R: Quantitative MR imaging R2* relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol 2006; 27: 430-439.
10. Moon W-J, Kim H-J, Roh HG, Choi JW, Han S-H: Fluid-attenuated inversion recovery hypointensity of the pulvinar nucleus of patients with Alzheimer disease: its possible association with iron accumulation as evidenced by the T2 map. Korean J Radiol 2012; 13: 674-683.
11. Zhu WZ, Zhong WD, Wang W, Zhan CJ, Wang CY, Qi JP, et al: Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. Radiology 2009; 253: 497-504.
12. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, et al: In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 2000; 57: 47-53.